1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

13 May 2024
Admin
News Article

Zinzino Acquires Assets in Xeliss in Southern Europe and in the Microalgae Spirulina

ZINZINO AB (PUBL): Zinzino acquires assets in Xeliss - strategic reinforcement in southern Europe and in the microalgae spirulina

Overview

Zinzino, the global health and wellness brand from Scandinavia, has acquired, through a business asset acquisition, the rights to the distributor database and associated customer register, inventory, and intellectual property of the Luxembourg-based direct sales company Xellis. This is a further strategically important step in Zinzino's growth plans, focusing on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.

Xelliss

Xelliss is a global direct sales company based in Luxembourg.
Its brand portfolio offers a range of natural and innovative products in wellness, nutrition, and cosmetics, based on the microalgae spirulina produced in-house.

Zinzino Vision

A visionary mindset, a tech-first approach, test-based nutrition at the cellular level, and a strong position to take advantage of current trends will shape the foundation of the partnership with Xellis.
Since the acquisition of VMA Life in 2020, Enhanzz in 2022, and the strategic cooperation with ACN at the start of 2024, Zinzino has been looking for additional powerful investments to maintain its sustainable, profitable growth, strengthen its distribution power, expand into new markets, and utilize its product portfolio in new consumer areas.

Words from CEO: Xellis

Individual advising and customized solutions are the future, not only in health and wellness, says Dag Bergheim Pettersen, CEO of Zinzino, and Jean-Michel Larré, CEO and founder of Xellis. Together, we have many years of combined industry experience and everything required to drive the modern, personal shopping experience through direct sales.

The Acquisition

Zinzino acquires Xelliss's distributor organization as well as inventory and IP rights to the product lines.
The operation, which had a turnover of approximately 8 million EUR last year, is expected to generate strong growth through the synergies created in the joint networks.
The operation's gross margins are good, and profitability will therefore be able to develop very well by utilizing Zinzino's existing technical platform and organization.

Zinzino Post Acquisition

At the time of entry, Zinzino will pay a fixed purchase price of 2 million EUR, divided into 50% cash and 50% newly issued Zinzino shares.
In addition, conditional additional purchase prices based on sales development generated by the acquired distributor organization during the period 2024–2029 will apply.
The total additional purchase prices are estimated to amount to 4.0 million EUR but could reach up to 8.0 million EUR at maximum outcome and will be regulated entirely with newly issued Zinzino shares.
The cash portion of the purchase price is financed with own cash.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!